Differences in Thyroid Function and Autoantibodies in the Development of Guillain–Barré Syndrome vs. Chronic Inflammatory Demyelinating Polyradiculoneuropathy-Reference-Cited by-同舟云学术

Differences in Thyroid Function and Autoantibodies in the Development of Guillain–Barré Syndrome vs. Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Published:2020-09-10 Issue: Volume:11 Page:
ISSN:1664-2295
Container-title:Frontiers in Neurology
language:
Short-container-title:Front. Neurol.

Author:

Tu Yu,Gong Xuan,Zeng Guanwen,Zhuo Wenyan,Li Zhaoxia,Yu Xueying

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Reference25 articles.

1. Corticosteroids for Guillain-Barré syndrome;Hughes;Cochrane Database Syst Rev.,2016

2. Fas-mediated T-cell apoptosis is impaired in patients with chronic inflammatory demyelinating polyneuropathy;Comi;J Peripher Nerv Syst,2006

3. European federation of neurological societies/peripheral nerve society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the european federation of neurological societies and the peripheral nerve society - first revision;Van den Bergh;Eur J Neurol,2010

4. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the american association of clinical endocrinologists and the american thyroid association;Garber;Thyroid,2012

5. Early neurophysiological evolution of chronic inflammatory demyelinating polyneuropathy in a patient with Hashimoto's thyroiditis;Bairactaris;Muscle Nerve,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypoglossal nerve involvement and sternocleidomastoid muscle atrophy in chronic inflammatory demyelinating polyneuropathy with Hashimoto's thyroiditis: A case report and literature review;Heliyon;2024-07

2. Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patients;Scientific Reports;2023-05-23

3. The prediction effects of thyroid function in the severity of Guillain-Barré syndrome;Neurological Sciences;2022-04-26

4. Serum thyroid‐stimulating hormone is an independent risk factor of recurrent Guillain‐Barré syndrome;Muscle & Nerve;2022-04-07

5. Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention;Journal of Oncology;2022-01-18